Bill Information for SB 13

SB 13 by Garvin and Marti

Select Session:

Enter Bill #:

Receive Email Updates for this Measure (LENS)

Pharmaceuticals; prohibiting certain drug plans to refuse dispensing certain drugs under certain circumstances; requiring certain drugs meet certain federal requirements; prohibiting patients from payment of certain fees beyond cost-sharing obligation; establishing penalties. Effective date. Emergency.

History

Amendments

Bill Summaries

Versions

Votes

Authors/Co Authors

History For SB 13

Action
Journal Page
Date
Chamber

First Reading 84 02/06/2023 S

Authored by Senator Garvin 84 02/06/2023 S

Second Reading referred to Retirement and Insurance Committee then to Appropriations Committee 304 02/07/2023 S

Reported Do Pass, amended by committee substitute Retirement and Insurance committee; CR filed 335 02/07/2023 S

Emergency added 335 02/07/2023 S

Referred to Appropriations 335 02/07/2023 S

Coauthored by Representative Marti (principal House author) 387 02/15/2023 S

Floor Amendments (Senate)

None

Floor Amendments (House)

None

Committee Amendments (Senate)

Committee Amendment 2/3/2023

Committee Amendments (House)

None

Sub Committee Recommendations (House)

None

Bill Summaries/Fiscal Impact for SB 13 (House)

None

Bill Summaries/Fiscal Impact for SB 13 (Senate)

Introduced 12/6/2022

Committee Substitute 2/7/2023

OPLAA Actuarial Statements For SB 13 (House)

None

OPLAA Actuarial Statements For SB 13 (Senate)

None

Fiscal Impact Statements For SB 13 (House)

None

Fiscal Impact Statements For SB 13 (Senate)

SB13 INT FI.PDF Fiscal (Senate)

Versions of SB 13

Introduced 12/6/2022

Committee Substitute 2/7/2023

Committee Reports for SB 13

Senate Committee Report 1 2/7/2023

Conference Committee Reports for SB 13

Votes on SB 13

SB13_VOTES.HTM All Senate Votes

Authors/Co Authors for SB 13

***To be added when the next official action is taken on the measure.***

Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105